{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:02Z","timestamp":1792698062602,"version":"4.5.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.lfs.2023.121685","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T05:41:00Z","timestamp":1681105260000},"page":"121685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Gut microbiome as a therapeutic target for liver diseases"],"prefix":"10.1016","volume":"322","author":[{"given":"Tejinder Pal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kadyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisha","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwoncheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/1040841X.2021.1902940","article-title":"Next-generation probiotics: a promising approach towards designing personalized medicine","volume":"47","author":"Singh","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/J.ENG.2017.01.008","article-title":"The human microbiota in health and disease","volume":"3","author":"Wang","year":"2012","journal-title":"Eng"},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1373208","article-title":"Intestinal barrier and gut microbiota: shaping our immune responses throughout life","volume":"5","author":"Takiishi","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.lfs.2023.121685_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s40168-021-01093-y","article-title":"From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators","volume":"9","author":"Han","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.lfs.2023.121685_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fmicb.2018.00151","article-title":"Gut microbiota: an integral moderator in health and disease","volume":"9","author":"Feng","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2023.121685_bb0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0016-5085(19)32137-7","article-title":"Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance","volume":"73","author":"Tarao","year":"1977","journal-title":"Gastroenterol"},{"key":"10.1016\/j.lfs.2023.121685_bb0035","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/gut.19.10.935","article-title":"Portal and systemic bacteraemia and endotoxaemia in liver disease","volume":"19","author":"Triger","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121685_bb0040","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3389\/fmicb.2018.01403","article-title":"Presence of segmented filamentous bacteria in human children and its potential role in the modulation of human gut immunity","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2023.121685_bb0045","first-page":"26191","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3920\/bm2015.0062","article-title":"Gut microbiota in health and disease: an overview focused on metabolic inflammation","volume":"7","author":"Nagpal","year":"2016","journal-title":"Benef. Microbes"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","article-title":"The gut microbiota and liver disease","volume":"1","author":"Llorente","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121685_bb0060","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3390\/ijms21218351","article-title":"The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage","volume":"21","author":"Plaza-D\u00edaz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.21037\/hbsn.2020.03.27","article-title":"The gut-liver axis as a target of liver disease management","volume":"10","author":"Mandato","year":"2021","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri2710","article-title":"Immune adaptations that maintain homeostasis with the intestinal microbiota","volume":"10","author":"Hooper","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0080","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1073\/pnas.1006451107","article-title":"The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions","volume":"108","author":"Johansson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121685_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0090","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"39","key":"10.1016\/j.lfs.2023.121685_bb0095","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0803124105","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"105","author":"Johansson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","article-title":"Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection","volume":"131","author":"Van der Sluis","year":"2006","journal-title":"Gastroenterol"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.2286","article-title":"Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation","volume":"214","author":"Kelsall","year":"2008","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121685_bb0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/glycob\/cwp048","article-title":"A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC\/MSn","volume":"19","author":"Larsson","year":"2009","journal-title":"Glycobiology"},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","article-title":"Bacterial adhesins in host-microbe interactions","volume":"5","author":"Kline","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2023.121685_bb0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","article-title":"Mucins and the microbiome","volume":"89","author":"Hansson","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.lfs.2023.121685_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Venegas","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mib.2011.11.002","article-title":"Role of mucus layers in gut infection and inflammation","volume":"15","author":"Hansson","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/femsre\/fuy003","article-title":"Pathogens, microbiome and the host: emergence of the ecological Koch's postulates","volume":"42","author":"Vonaesch","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10409238.2016.1243654","article-title":"Defensins, lectins, mucins, and secretory immunoglobulin a: microbe-binding biomolecules that contribute to mucosal immunity in the human gut","volume":"52","author":"Chairatana","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.121685_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2023.121685_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683022","article-title":"Maternal microbiota, early life colonization and breast milk drive immune development in the newborn","volume":"12","author":"Kalbermatter","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11894-010-0130-3","article-title":"Intestinal stem cells","volume":"12","author":"Umar","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.17.2.375","article-title":"Junctional complexes in various epithelia","volume":"17","author":"Farquhar","year":"1963","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.lfs.2023.121685_bb0170","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2023.121685_bb0180","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1126\/science.1102901","article-title":"CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance","volume":"307","author":"Niess","year":"2005","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.lfs.2023.121685_bb0185","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1084\/jem.20061884","article-title":"Germain; dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement","volume":"203","author":"Chieppa","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2023.121685_bb0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41577-018-0013-7","article-title":"Diverse developmental pathways of intestinal intraepithelial lymphocytes","volume":"18","author":"McDonald","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121685_bb0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nat"},{"key":"10.1016\/j.lfs.2023.121685_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7500","key":"10.1016\/j.lfs.2023.121685_bb0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature13160","article-title":"T-cell activation by transitory neo-antigens derived from distinct microbial pathways","volume":"509","author":"Corbett","year":"2014","journal-title":"Nat"},{"key":"10.1016\/j.lfs.2023.121685_bb0210","doi-asserted-by":"crossref","first-page":"E5434","DOI":"10.1073\/pnas.1705759114","article-title":"Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines","volume":"114","author":"Dias","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.121685_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.12688\/f1000research.13020.1","article-title":"Update on regulation and effector functions of Th17 cells","volume":"7","author":"Sandquist","year":"2018","journal-title":"F1000Research"},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","article-title":"The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses","volume":"31","author":"Gaboriau-Routhiau","year":"2009","journal-title":"Immun"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.121685_bb0230","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis","volume":"9","author":"Sharma","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0235","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1084\/jem.20160525","article-title":"Emerging concepts and future challenges in innate lymphoid cell biology","volume":"213","author":"Tait Wojno","year":"2016","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12275-018-7565-x","article-title":"Type 3 regulatory T cells at the interface of symbiosis","volume":"56","author":"Park","year":"2018","journal-title":"J. Microbiol."},{"key":"10.1016\/j.lfs.2023.121685_bb0245","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterol"},{"key":"10.1016\/j.lfs.2023.121685_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn's disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2023.121685_bb0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.lfs.2023.121685_bb0260","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.121685_bb0265","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0270","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0285","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/joim.12140","article-title":"Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism","volume":"275","author":"Hu","year":"2014","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0300","doi-asserted-by":"crossref","first-page":"G996","DOI":"10.1152\/ajpgi.90343.2008","article-title":"Beta-klotho and FGF-15\/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes","volume":"295","author":"Sinha","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2023.121685_bb0305","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"issue":"7405","key":"10.1016\/j.lfs.2023.121685_bb0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nat"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0320","first-page":"147","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol. Res."},{"issue":"37","key":"10.1016\/j.lfs.2023.121685_bb0325","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.3748\/wjg.v13.i37.4974","article-title":"Alcohol-induced steatosis in liver cells","volume":"13","author":"Donohue","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0168-8278(97)80144-4","article-title":"CYP2E1 activity in patients with alcoholic liver disease","volume":"27","author":"Dilger","year":"1997","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0335","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acer.12209","article-title":"MiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cells","volume":"38","author":"Dong","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0340","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.510230431","article-title":"Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration","volume":"23","author":"Tuma","year":"1996","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0345","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biocel.2012.10.002","article-title":"Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1","volume":"45","author":"Thomes","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0350","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4291\/wjgp.v7.i1.17","article-title":"Adipose tissue-liver axis in alcoholic liver disease","volume":"7","author":"Wang","year":"2016","journal-title":"World J. Gastrointest. Pathophysiol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055382","article-title":"Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091308","article-title":"Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121685_bb0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2015.11.013","article-title":"Deletion of GSTA4-4 results in increased mitochondrial post-translational modification of proteins by reactive aldehydes following chronic ethanol consumption in mice","volume":"7","author":"Shearn","year":"2016","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0370","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2006.08.024","article-title":"Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway","volume":"46","author":"Kharbanda","year":"2007","journal-title":"J. Hepatol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121685_bb0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-009-0044-2","article-title":"Betaine administration corrects ethanol-induced defective VLDL secretion","volume":"327","author":"Kharbanda","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053028","article-title":"Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment","volume":"8","author":"Bull-Otterson","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0385","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatol"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatol"},{"issue":"9","key":"10.1016\/j.lfs.2023.121685_bb0395","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0400","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.lfs.2023.121685_bb0405","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.121685_bb0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-59745-242-7_13","article-title":"Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer","volume":"447","author":"Rao","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054646","article-title":"Chronic alcohol exposure renders epithelial cells vulnerable to bacterial infection","volume":"8","author":"Wood","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0420","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.26321","article-title":"Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice","volume":"58","author":"Hartmann","year":"2013","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0425","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0430","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0029-1214373","article-title":"\"Second hit\" models of alcoholic liver disease","volume":"29","author":"Tsukamoto","year":"2009","journal-title":"Semin. Liver Dis."},{"issue":"25","key":"10.1016\/j.lfs.2023.121685_bb0435","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0440","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0445","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatol"},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0450","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatol"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0460","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0465","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/nu12030820","article-title":"Gut microbiota dysbiosis in patients with biopsy-proven nonalcoholic fatty liver disease: a cross-sectional study in Taiwan","volume":"12","author":"Tsai","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213692","article-title":"Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects","volume":"14","author":"Yun","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1499-3872(15)60026-1","article-title":"Gut microbiota and non-alcoholic fatty liver disease","volume":"14","author":"Gkolfakis","year":"2015","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.lfs.2023.121685_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the gut microbiota in regulating non-alcoholic fatty liver disease in children and adolescents","volume":"8","author":"Tokuhara","year":"2021","journal-title":"Front. Nutr."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0485","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/nu9111220","article-title":"Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis","volume":"9","author":"Chiu","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0490","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/microorganisms9010199","article-title":"Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Burz","year":"2021","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0495","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1249\/MSS.0000000000001495","article-title":"Exercise alters gut microbiota composition and function in lean and obese humans","volume":"50","author":"Allen","year":"2018","journal-title":"Med. Sci. Sports Exerc."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0500","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41390-018-0156-z","article-title":"Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice","volume":"85","author":"Hu","year":"2019","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.lfs.2023.121685_bb0505","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0510","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0515","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatol"},{"key":"10.1016\/j.lfs.2023.121685_bb0520","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1038\/s41598-020-66241-0","article-title":"Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools","volume":"10","author":"Lang","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0525","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatol"},{"issue":"8","key":"10.1016\/j.lfs.2023.121685_bb0530","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.14106","article-title":"Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids","volume":"39","author":"Jin","year":"2019","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0535","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ijo.2016.23","article-title":"Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate","volume":"40","author":"Sahuri-Arisoylu","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.lfs.2023.121685_bb0540","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.121685_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.07.022","article-title":"Propionate suppresses hepatic gluconeogenesis via GPR43\/AMPK signaling pathway","volume":"672","author":"Yoshida","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2023.121685_bb0550","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada","year":"2019","journal-title":"Front. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.lfs.2023.121685_bb0555","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.nut.2004.12.004","article-title":"Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation","volume":"21","author":"Ohata","year":"2005","journal-title":"Nutr"},{"key":"10.1016\/j.lfs.2023.121685_bb0560","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fped.2019.00518","article-title":"Metagenome of gut microbiota of children with nonalcoholic fatty liver disease","volume":"7","author":"Zhao","year":"2019","journal-title":"Front. Pediatr."},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0565","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12072-019-09987-8","article-title":"Significant decrease in faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study","volume":"13","author":"Iino","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.lfs.2023.121685_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112298","article-title":"Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment","volume":"144","author":"Liang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0575","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","article-title":"Choline: an essential nutrient for public health","volume":"67","author":"Zeisel","year":"2009","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.lfs.2023.121685_bb0580","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/nu12082340","article-title":"The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases","volume":"12","author":"Arias","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0585","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40168-017-0271-9","article-title":"Uncovering the trimethylamine-producing bacteria of the human gut microbiota","volume":"5","author":"Rath","year":"2017","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0590","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"MBio"},{"issue":"23","key":"10.1016\/j.lfs.2023.121685_bb0595","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0600","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lfs.2023.121685_bb0605","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/modpathol.3880119","article-title":"Liver pathology: cirrhosis, hepatitis, and primary liver tumors.Update and diagnostic problems","volume":"13","author":"Ferrell","year":"2000","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0610","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.lfs.2023.121685_bb0615","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1872-034X.2011.00822.x","article-title":"Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis","volume":"41","author":"Seki","year":"2011","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0620","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0037-1608832","article-title":"Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in chronic liver disease","volume":"37","author":"Shah","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2023.121685_bb0625","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nat"},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0630","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0635","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep4.1256","article-title":"FXR and TGR5 agonists ameliorate liver injury, steatosis, and inflammation after binge or prolonged alcohol feeding in mice","volume":"2","author":"Iracheta-Vellve","year":"2018","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0640","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","article-title":"The role of inflammation in cholestasis: clinical and basic aspects","volume":"30","author":"Kosters","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2023.121685_bb0645","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","article-title":"Bile acid synthesis: from nature to the chemical modification and synthesis and their applications as drugs and nutrients","volume":"9","author":"\u0160arenac","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0650","doi-asserted-by":"crossref","first-page":"336","DOI":"10.14218\/JCTH.2020.00036","article-title":"Primary sclerosing cholangitis and primary biliary cirrhosis overlap syndrome: a review","volume":"8","author":"Mago","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121685_bb0655","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/jcm10081763","article-title":"The management of cholestatic liver diseases: current therapies and emerging new possibilities","volume":"10","author":"Mazzetti","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0660","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterol"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0665","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3727\/105221619X15536120524171","article-title":"Current and emerging approaches for nonalcoholic steatohepatitis treatment","volume":"19","author":"Chen","year":"2019","journal-title":"Gene Expr."},{"issue":"13","key":"10.1016\/j.lfs.2023.121685_bb0670","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1074\/jbc.M115.699504","article-title":"Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet \u03b1 cells to promote glucose homeostasis","volume":"291","author":"Kumar","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0675","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"24","key":"10.1016\/j.lfs.2023.121685_bb0680","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2023.121685_bb0685","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11892-017-0918-8","article-title":"Weight management in patients with type 1 diabetes and obesity","volume":"17","author":"Mottalib","year":"2017","journal-title":"Curr. Diab. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0690","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/oby.22347","article-title":"A randomized, double-blind, placebo-controlled study of gelesis100: a novel nonsystemic oral hydrogel for weight loss","volume":"27","author":"Greenway","year":"2019","journal-title":"Obes"},{"key":"10.1016\/j.lfs.2023.121685_bb0695","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/pola.28703","article-title":"Polymers as drugs\u2014advances in therapeutic applications of polymer binding agents","volume":"55","author":"Connor","year":"2017","journal-title":"J. Polym. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2023.121685_bb0700","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/17460441.2018.1538206","article-title":"Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes","volume":"13","author":"Nerild","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.lfs.2023.121685_bb0705","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CE.S26725","article-title":"Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action","volume":"7","author":"Zema","year":"2012","journal-title":"Core Evid."},{"issue":"11","key":"10.1016\/j.lfs.2023.121685_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity","volume":"9","author":"McCarville","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2023.121685_bb0715","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.00041-08","article-title":"Tolevamer, an anionic polymer, neutralizes toxins produced by the BI\/027 strains of Clostridium difficile","volume":"52","author":"Hinkson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2023.121685_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(15)30110-0","article-title":"Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation","volume":"62","author":"Macnaughtan","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0725","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J. Hepatol."},{"issue":"36","key":"10.1016\/j.lfs.2023.121685_bb0730","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3748\/wjg.v28.i36.5280","article-title":"Liver-specific drug delivery platforms: applications for the treatment of alcohol-associated liver disease","volume":"28","author":"Warner","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121685_bb0735","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol. Hepatol. Rev."},{"key":"10.1016\/j.lfs.2023.121685_bb0740","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/382184","article-title":"Efficient hepatic delivery of drugs: novel strategies and their significance","volume":"2013","author":"Mishra","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2023.121685_bb0745","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"B\u00f6ttger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2023.121685_bb0750","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12951-022-01708-y","article-title":"Polymeric nanomedicines for the treatment of hepatic diseases","volume":"20","author":"Luo","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0755","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13105-015-0390-3","article-title":"Gut microbiota: a key player in health and disease. A review focused on obesity","volume":"71","author":"Villanueva-Mill\u00e1n","year":"2015","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2023.121685_bb0760","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41430-021-00991-6","article-title":"Role of the gut microbiome in chronic diseases: a narrative review","volume":"76","author":"Vijay","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"issue":"14","key":"10.1016\/j.lfs.2023.121685_bb0765","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.3390\/jcm11144119","article-title":"Fecal microbiota transplantation as new therapeutic avenue for human diseases","volume":"11","author":"Biazzo","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0770","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/hep.30827","article-title":"Neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatol"},{"issue":"4","key":"10.1016\/j.lfs.2023.121685_bb0775","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0780","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.121685_bb0785","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol Med Public Health"},{"issue":"10","key":"10.1016\/j.lfs.2023.121685_bb0790","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0795","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121685_bb0800","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3390\/ijms23052896","article-title":"Overview of the importance of biotics in gut barrier integrity","volume":"23","author":"Kocot","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121685_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.121685_bb0810","article-title":"Effects of probiotics on the lipid profile: systematic review","volume":"18","author":"Gadelha","year":"2019","journal-title":"J. Vasc. Bras."},{"issue":"3","key":"10.1016\/j.lfs.2023.121685_bb0815","doi-asserted-by":"crossref","first-page":"792","DOI":"10.5114\/aoms.2019.89894","article-title":"Antioxidative activity of probiotics","volume":"17","author":"Hoffmann","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2023.121685_bb0820","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.lfs.2023.121685_bb0825","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121685_bb0830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fmed.2014.00015","article-title":"Gut microbiota: the next-gen frontier in preventive and therapeutic medicine?","volume":"1","author":"Nagpal","year":"2014","journal-title":"Front. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523003193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523003193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T01:10:31Z","timestamp":1736385031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":166,"alternative-id":["S0024320523003193"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121685","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome as a therapeutic target for liver diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121685"}}